R RYTM

Rhythm Pharmaceuticals Inc

$86.44

-7.49% ($7.00)

Volume 7.11M

52W High $122.20

52W Low $74.50

Market Cap $6.43B

Next Earnings Report

Last Reported

Nov 3, 2026 Missed

Actual: -$0.82 vs. Consensus: -$0.68

Last 11 quarters

Q2 2026 Aug 4, 2026

1-Day: +4.66%

Q1 2026 May 12, 2026

1-Day: +2.64%

Q1 2026 May 5, 2026

1-Day: +4.66%

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$57.3M	+36.9%	91.6%	-82.2%	-$47.5M
Q3'25	$51.3M	+54.3%	89.3%	-102.6%	-$52.9M
Q2'25	$48.5M	+66.8%	88.6%	-93.4%	-$46.6M
Q1'25	$32.7M	+25.9%	88.9%	-143.7%	-$49.5M
Q4'24	$41.8M	+72.6%	91.0%	-98.6%	-$43.3M
Q3'24	$33.3M	+47.8%	88.5%	-132.0%	-$43.6M
Q2'24	$29.1M	+51.3%	89.9%	-139.2%	-$32.3M
Q1'24	$26.0M	+126.4%	89.2%	-538.7%	-$141.4M

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Nov 3, 2026	-$0.68	-$0.74	-$0.82	-20.59%	Missed
Q2 2026	Aug 4, 2026	-$0.81	-$0.81	-$0.73	+9.88%	Beat
Q1 2026	May 12, 2026	-$0.82	-$0.82	-$0.83	-1.07%	Missed
Q1 2026	May 5, 2026	-$0.86	-$0.86	-$0.83	+3.49%	Beat
Q4 2025	Mar 4, 2026	-$0.82	-$0.83	-$0.73	+11.17%	Beat
Q4 2025	Feb 26, 2026	-$0.79	-$0.78	-$0.73	+7.59%	Beat
Q4 2025	Feb 25, 2026	-$0.78	-$0.78	--	--	--
Q3 2025	Nov 4, 2025	-$0.73	-$0.71	-$0.82	-12.33%	Missed
Q2 2025	Aug 5, 2025	-$0.67	-$0.67	-$0.75	-11.94%	Missed
Q1 2025	May 7, 2025	-$0.68	-$2.16	-$0.81	-19.12%	Beat
Q1 2025	May 5, 2025	-$2.16	-$2.16	-$0.81	+62.50%	Beat
Q4 2024	Feb 26, 2025	-$0.73	-$0.73	-$0.72	+1.37%	Beat